Articles by Sandy Weinberg, PhD - BioPharm International

ADVERTISEMENT

ADVERTISEMENT
Articles by Sandy Weinberg, PhD

Funding Biodefense Vaccine Development

Alternative sources that spin-off companies can tap into.
Apr 1, 2009
By: Sandy Weinberg, PhD

Biodefense start-up companies have an abundance of options when seeking funding.

Serving Two Masters: Reconciling EMEA/GAMP 5 and FDA/cGMP Phase 1

QbD can help satisfy FDA and EMEA requirements.
Jan 1, 2009
By: Sandy Weinberg, PhD

QbD can help satisfy FDA and EMEA requirements.

ADVERTISEMENT

ADVERTISEMENT
Click here